Finland: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Finland

The Finnish human and animal blood market was estimated at $X in 2022, approximately equating the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations being observed throughout the analyzed period. Over the period under review, the market attained the peak level at $X in 2018; however, from 2019 to 2022, consumption stood at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Finland

In value terms, human and animal blood production reached $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations being observed in certain years. The pace of growth was the most pronounced in 2013 when the production volume increased by X%. Human and animal blood production peaked at $X in 2018; however, from 2019 to 2022, production stood at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Finland

For the third consecutive year, Finland recorded decline in shipments abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, which decreased by X% to X tons in 2022. In general, exports showed a pronounced decline. The growth pace was the most rapid in 2014 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2015 to 2022, the growth of the exports failed to regain momentum.

In value terms, human and animal blood exports reached $X in 2022. Overall, total exports indicated a slight increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2018 when exports increased by X%. The exports peaked at $X in 2019; however, from 2020 to 2022, the exports failed to regain momentum.

Exports by Country

Austria (X tons) was the main destination for human and animal blood exports from Finland, accounting for a X% share of total exports. Moreover, human and animal blood exports to Austria exceeded the volume sent to the second major destination, China (X tons), fivefold. The third position in this ranking was held by Russia (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume to Austria amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and Russia (X% per year).

In value terms, Austria ($X) remains the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from Finland, comprising X% of total exports. The second position in the ranking was taken by Russia ($X), with an X% share of total exports. It was followed by China, with a X% share.

From 2012 to 2022, the average annual growth rate of value to Austria totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Russia (X% per year) and China (X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2022, surging by X% against the previous year. Overall, export price indicated a temperate increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, human and animal blood export price increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2018 when the average export price increased by X%. The export price peaked in 2022 and is expected to retain growth in years to come.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was the UK ($X,317 per ton), while the average price for exports to Estonia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Finland

In 2022, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were imported into Finland; shrinking by X% compared with the previous year. Over the period under review, imports showed a abrupt setback. The most prominent rate of growth was recorded in 2020 with an increase of X%. Over the period under review, imports hit record highs at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, human and animal blood imports contracted dramatically to $X in 2022. Overall, imports continue to indicate a pronounced contraction. The most prominent rate of growth was recorded in 2017 when imports increased by X%. As a result, imports attained the peak of $X. From 2018 to 2022, the growth of imports failed to regain momentum.

Imports by Country

Sweden (X tons), Denmark (X tons) and Germany (X tons) were the main suppliers of human and animal blood imports to Finland, with a combined X% share of total imports. The UK, the Netherlands, Russia and the United States lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the biggest increases were recorded for Russia (with a CAGR of X%), while purchases for the other leaders experienced a decline.

In value terms, Sweden ($X), the United States ($X) and Germany ($X) constituted the largest human and animal blood suppliers to Finland, together accounting for X% of total imports. Denmark, the UK, the Netherlands and Russia lagged somewhat behind, together comprising a further X%.

Among the main suppliers, Russia, with a CAGR of X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, picking up by X% against the previous year. Over the period under review, the import price saw strong growth. The pace of growth appeared the most rapid in 2017 when the average import price increased by X% against the previous year. The import price peaked in 2022 and is likely to see gradual growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the United States ($X,128 per ton), while the price for Russia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Sweden (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :